Tumor necrosis factor (TNF) was originally found in the sera of Mycobacterium bovis BCG-infected mice which had been challenged with endotoxin (5) . In addition to lipopolysaccharide (LPS), other stimulators can induce TNF, e.g., the streptococcal antigen OK-432 (1), Sendai virus (32) , and circulating immune complexes (23) . In addition to its antitumor effects in vitro and in vivo (19) , TNF has been shown to have immunopotentiating properties. Recently, human TNF was reported to enhance the phagocytic activity in human polymorphonuclear neutrophils (PMN) (16, 24) and to mediate natural cytotoxic cell activity (20) . TNF has also been shown to be directly cytolytic for Plasmodium spp. (28) and to stimulate the antiparasitic activity of eosinophils (25) . In contrast to its cytostatic and cytolytic effects, TNF has also been shown to stimulate the growth of some cell lines (30) and to mediate the adherence of PMN to endothelial cells (11) . TNF has also been identified as cachectin, a protein which is responsible for wasting and weight loss in rodents (2) . Some of the activities reported for TNF appear to be synergistically enhanced with gamma interferon (IFN--y). For example, a cooperative effect between TNF and IFN-,y in their antiproliferative activity on treated cell lines and in enhanced target cell killing of normal and tumor cells in humans has been reported (27) . Also, the addition of both IFN-,y and human recombinant TNF to PMN results in higher phagocytic activity and oxidative metabolism than does the addition of either cytokine alone (16, 24) . This synergy is possibly due to the induction of TNF receptor expression by IFN--y (22, 29) and suggests that TNF may participate in the cytokine cascade during an immune response. Legionella pneumophila is a facultative intracellular bacterium that has been associated with human pulmonary * Corresponding author. infection (7) . Recent studies indicated that cellular immunity plays a major role in resistance to this organism. Whereas the presence of anti-Legionella antibody does not appear to be protective in experimental infections (14) , activation of infected macrophages with cytokine-containing fluids enhances intracellular killing of the bacterium (13 (26) . Twenty-five microliters of a bacterial suspension or control fluids was injected directly into the trachea of anesthetized mice. Specimen preparation. Mice were sacrificed by using dry ice-generated CO2 gas chambers. For TNF and IFN assays of specimens from infected mice, sera and lung lavage fluid were collected. Blood samples were obtained via cardiac puncture and allowed to coagulate. To obtain lung lavage fluid, the animal was tethered as for inoculation and a blunt cannula was inserted through the mouth into the trachea. Complete medium (1 ml) was twice injected into the lung and withdrawn. The fluid was passed through a microfilter (pore size, 0.22 ,um; Millipore Corp., Bedford, Mass.) to remnove bacteria, cells, and debris. Complete tnedium consisted of RPMI 1640 (GIBCO Laboratories, Grand Island, N.Y.) with 10% fetal calf serum (Hyclone, Logan, Utah), penicillinstreptomycin (Sigma), and 5 x 10-5 M 2-mercaptoethanol (Sigma). Recovery was typically 0.7 to 0.8 ml of fluid per mouse, and the lung lavage fluid was used for assay within 2 days of recovery.
For in vitro induction of TNF, lung leukocytes from uninfected mice were used. Lung tissues were removed from exsanguinated mice and were minced and processed in a Stomacher (Tekmar, Cincinnati, Ohio) to obtain cell suspensions. The suspension was passed through a wire screen to remove large chunks of tissue and then centrifuged over Lympholyte-M (Cedarlane Labs, Westbury, N.Y.) to remove parenchymal cells and debris. The leukocytes were collected from the interface and washed in Hanks balanced salt solution. Cells were used at a concentration of 106 cells bThe numbers in parentheses indicate the amount of IFN activity remaining after neutralization with monoclonal anti-IFN-y antibodies.
per ml of complete medium. Typically, recovery ranged from 0.5 x 106 to 1.5 x 106 cells per mouse.
The murine macrophagelike cell line PU 5-1.8 was cultured in minimal essential medium (GIBCO) with 10% fetal calf serum and antibiotics. For stimulation, cells were diluted to 106/ml of medium, and 1 ml was used per well of a 24-well tissue culture plate (Becton Dickinson Labware, Oxnard, Calif.).
TNF assay. Samples were serially diluted in 96-well flatbottom microtiter plates. Cells (2.5 x 104) from the cell suspension were added to each well, and the plate was: incubated at 37°C in a 5% CO2 incubator for 24 to 48 h. The monolayer was then microscopically examined for cytolytic activity. The samples were assayed simultaneously on Lm(S) cells, which are TNF sensitive, and Lm(R) cells, which are TNF-resistant. These cells were generously provided by E. A. Carswell (31) . Selected samples were neutralized with anti-cachectin antibodies (3) , which were a generous gift from B. Beutler, before assay. Titers are expressed as the reciprocal of the dilution of the sample in which 50% of the cells in the monolayer were lysed. A laboratory standard, which was obtained from phorbol myristate acetate-stimulated LuKII cells (31) , was included in each assay.
IFN assay. Antiviral activity was determined as described previously (4) TNF (3) . No TNF activity was detected in the lungs of saline-treated mice at any time or in the lavage fluid of control mice. IFN was detected in the lung lavage fluid of Legionella-infected mice as early as 3 h postinfection, and maximum levels were produced earlier than those of TNF, i.e., at 6 to 9 h, after which time, titers slowly decreased.
The antiviral activity was neutralized by anti-IFN-y antibodies, indicating that the IFN was the gamma type.
Serum specimens were collected at the same time intervals as the lung lavage fluid and were also assayed for TNF and IFN (Table 2) . IFN was detected in the circulation by 6 h postinfection, and maximum levels Were present at about 9 h. IFN was still present at 3 days, although only at low levels. This IFN was also determined, with monoclonal antibodies, to be IFN--y. There was no TNF detected at any time in the sera of infected mice.
To show that a dose response existed for the induction of TNF, various amounts of bacteria were inoculated into the lungs of normal mice, and lung lavage fluid was collected 24 h later for assay (Fig. 1) . The inoculation of one 50% lethal dose (3 x 106 bacteria per animal) resulted in maximal production of TNF, and a lethal dose (107 bacteria per animal) stinmulated similar levels of TNF. The injection of pyrogen-free saline, latex particles, or killed Legionella cells ("vaccine") at a concentration of 3 x 106 particles per animal did not induce TNF (also see Table 6 ). It should be noted that killed bacterial cells were capable of inducing TNF when much higher numbers of cells (108 per animal) were used.
To determine the cellular source of TNF, lung leukocytes were obtained from normal mice and were used either unseparated or after separation into adherent and nonadherent populations. The cultures were stimulated with Escherichia coli LPS or L. pneumophila killed-cell vaccine, and the supernatants were collected at the indicated times ( Table  3 ). The Legionella vaccine was capable of inducing detectable amounts of TNF in the unseparated leukocytes and in the adherent cell populations. The nonadherent leukocytes did not respond to stimulation by producing TNF, although IFN-y was produced in these cell cultures. Since E. coli LPS has been reported to induce TNF in macrophage cultures (17) , it was included here as a positive control for the induction conditions. As with the Legionella killed-cell vaccine, LPS induced TNF in the unfractionated and adherent cells, although at higher levels, suggesting that macrophages were involved. With both inducers, TNF was present at 24 h after stimulation, remained at about the same level at 48 h, and decreased by 72 h. Furthermore, adherent lung leukocytes obtained from infected mice released TNF into the culture medium (Table 4) , and the presence of the bacterial vaccine further stimulated TNF production. Peak spontaneous release of TNF was seen on day 1 after inoculation, correlating with in vivo kinetics ( Table 1) . No IFN was detected in any of these cultures (data not shown).
To examine the cellular source of TNF in response to stimulation with Legionella antigens, a macrophagelike cell (21) . These cells were cultured at a concentration of 106 cells per ml and were stimulated with LPS or killed Legionella cells. The results (Table 5 ) were similar to those seen when the lung leukocyte populations were used. This TNF was also neutralized with anti-cachectin antibodies. Pretreatment of the cells with 100 U of recombinant IFN--y (rIFN-y) per ml for 1 h before addition of stimulators resulted in augmented levels of TNF.
Since it appeared that macrophages were responsible for TNF production in vitro, the effect of in vivo depletion of macrophage activity was explored. Mice were injected intraperitoneally with 50 mg of DS per kg of body weight 24 h before inoculation. This dose had been reported to specifically suppress macrophage function in a murine listeriosis infection model (8, 9) , although the effect of DS treatment on the alveolar macrophages was not explored in this model. The lung lavage fluids were collected at 24 h postinfection and assayed for TNF. The DS-treated mice produced lower levels of TNF than did controls injected with the same number of bacteria (Table 6 ). This indicated that macrophages were responsible for TNF production in vivo as well as in vitro.
DISCUSSION
In this study, live Legionella organisms stimulated the production of TNF and IFN in the lungs of mice during infection. Levels of TNF were maximal at about 24 h after infection and diminished by 48 h. This loss of activity was possibly due to either the proteases present in the normal lung or distribution of the TNF to other parts of the body and indicated that production of TNF occurred early in infection and not continuously during infection. Lethally infected mice succumbed at 3 to 8 days postinoculation, suggesting that TNF was not a direct cause of death since significant TNF activity was not detectable after 48 h. The induction of IFN--y during the early stages of infection may indicate cooperativity between the two cytokines. Studies using human monocytes have demonstrated that IFN-y augments the production of TNF (18) , and a similar relationship may have occurred in the present study since IFN--y was detectable 12 to 18 h before TNF. In our study, pretreatment of a macrophagelike cell line with IFN-,y resulted in enhanced TNF production when the cells were stimulated with L. pneumophila or LPS. IFN-y has also been shown to augment the activities of TNF with regard to cytotoxicity (15) , PMN function (24) , and antiproliferative effects (27) . Additionally, IFN--y has been shown to induce cellular receptors for TNF on tumor cell lines (22, 29) , which may account for the synergism between them. The relationships between TNF and IFN--y are under investigation in our experimental infection model.
It is not clear why TNF was not detected in serum, although IFN--y was present. In the original model of TNF induction, BCG infection of mice is not sufficient to induce TNF and endotoxin is required to detect cytotoxic activity in the serum (5) . In the present model, it is possible that TNF was confined to the localized infection in the lung and was not detected in the blood because of low production, local catabolism, or binding to lung cells, endothelial cells, and PMN. It is also possible that there are inactivators of TNF activity in serum and only under conditions in which overwhelming production of TNF is stimulated is it possible to detect it systemically.
Using lung leukocyte cultures, it was determined that the adherent cell population was responsible for TNF production in response to Legionella killed-cell vaccine or E. coli LPS. Based on this finding, it is suggested that alveolar macrophages were the responding cell type. The use of the murine macrophagelike cell line PU 5-1.8 further indicated that macrophages were responsible for TNF production when stimulated with Legionella killed-cell vaccine. These cells have been reported to produce TNF in response to LPS (17) , and in the present study they responded to killed Legionella cells. It should be noted that the use of killed Legionella bacteria in vitro was done to avoid direct cytotoxicity from live bacteria or their by-products in the assay systems. Although greater numbers of the killed organism were required to incude TNF in vivo, it was apparent that the animals would respond to the vaccine.
Since treatment of mice with DS before infection suppressed the induction of TNF, it is suggested that macrophages were involved in TNF production in vivo. DS was used to specifically interfere with macrophage activity (8, 9, 12) . The inability of DS treatment to completely abrogate TNF production may have been due to incomplete neutralization of alveolar macrophages, which are possibly more inaccessible than other macrophage populations, e.g., splenic, liver, and peritoneal cells, which are inactivated by DS treatment (9) . It should also be mentioned that increased doses of DS resulted in mortality of the treated animal, indicating that a dose of 50 mg/kg was maximal in our system. The induction of TNF by E. coli LPS has been well documented (5, 17) and may account for the response to Legionella killed-cell vaccine, which also contains LPS. However, in preliminary studies, infection of C3H/HeJ mice with L. pneumophila resulted in equivalent levels of TNF in the lung lavage fluid (data not shown). This suggests that factors other than LPS (possibly an LPS-associated protein) may be involved in the induction model. In this regard, recent studies indicated that pretreatment of C3H/HeJ macrophages with IFN-y allows the production of TNF when high concentrations of endotoxin are applied (2) . Since killed bacterial cells have been shown to induce IFN-y in splenocyte cultures from both C3H/HeJ and BDF1 mice (4), IFN may play a role in the induction of TNF.
Based on the present study, it is apparent that TNF is induced in the lungs of Legionella-infected mice early in the infection. It can be speculated that the role of TNF in INFECT. IMMUN. on October 28, 2017 by guest http://iai.asm.org/ Downloaded from bacterial infections involves a variety of responses, since this cytokine has been reported to stimulate a diversity of cells. Although the traditional cytostatic and cytolytic effects of TNF may not be relevant in this model, the stimulation of PMN functions (antibody-dependent cell-mediated cytotoxicity and phagocytosis) may help to limit the growth of the bacterium soon after infection. On the other hand, cachectinTlNF has been reported to be toxic to mice (6) , and its induction during an infection may contribute to the pathogenicity of the bacterium.
